Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus
- 25 March 2020
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 177, 104782
- https://doi.org/10.1016/j.antiviral.2020.104782
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI127031)
This publication has 27 references indexed in Scilit:
- Traditional and New Influenza VaccinesClinical Microbiology Reviews, 2013
- Highly Conserved Protective Epitopes on Influenza B VirusesScience, 2012
- Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling studyThe Lancet Infectious Diseases, 2012
- Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral HemagglutininPLOS ONE, 2011
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A HemagglutininsScience, 2011
- Novel Inhibitors of Influenza Virus Fusion: Structure-Activity Relationship and Interaction with the Viral HemagglutininJournal of Virology, 2010
- Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United StatesJAMA, 2009
- Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian InfluenzaJournal of Virology, 2009
- Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusionProceedings of the National Academy of Sciences, 2008
- Characterization of a Hemagglutinin-Specific Inhibitor of Influenza A VirusVirology, 1996